ONXX
Onyx Pharmaceuticals

Conference date: November 3, 2009 @ 2:00 PM Pacific Time

Onyx Pharmaceuticals Acquires Proteolix, Carfilzomib [October 12, 2009]
Onyx Breast Cancer Trial Results [September 30, 2009]
Onyx Positive Surprise for Investors [November 11, 2008]

Analyst Conference Summaries Available:

2009
Onyx (ONXX) analyst conference summary Q4 2008
Onyx Pharmaceuticals ONXX analyst conference summary q1 2009
Onyx Pharmaceuticals ONXX analyst conference summary Q2 2009
Onyx Pharmaceuticals ONXX analyst conference summary Q3 2009
02/23/2009
05/06/2009
 08/04/2009
11/03/2009
Q4 2008
Q1 2009
 Q2 2009
Q3 2009  
2008
Onyx analyst conference summary Q3 2008
Onyx (ONXX) analyst conference summary Q2 2008
Onyx Q1 analyst conference summary 2008
Onyx Q4 2007 analyst conference summary
11/06/2008
08/05/2008
05/06/2008
02/19/2008
Q3 2008
Q2 2008
Q1 2008
Q4 2007
2007
Onyx analyst conference summary Q3 2007
ONXX Q2 2007 summary
ONXX summary
ONXX Q4 2006 summary
11/06/2007
08/07/2007
05/09/2007
02/15/2007
Q3 2007
Q2 2007
Q1 2007
Q4 2006
2006
ONXX Q3 2006 summary
ONXX Q2 2006 summary
ONXX Q1 2006 summary
11/07/2006
08/08/2006
05/05/2006
Q3 2006
Q2 2006
Q1 2006

Onyx Chooses the Long Run [August 11, 2008]
Onyx In The Black [May 7, 2008]
Onyx (ONXX) Nexavar Trial and Q4 results comments [February 20, 2008]
Can Onyx Deliver? [May 10, 2007]

First bought on May 9, 2008

Onyx Web site:

main page
investor page

Onyx (ONXX) is a biotech or pharmaceutical company. Its primary product is Nexavar for kidney and liver cancer.

Disclaimer: Our analyst summaries may include both our condensations of statements made by company representatives and our own analysis. They are not covered by any warranty. We cannot guarantee anything said by company representatives is true. Before making or terminating an investment you should always verify any factual basis of your decision.